Cardiovascular Disease
Medicare to cover semaglutide for CV prevention for adults with overweight and obesity
Medicare Part D plans can begin to cover semaglutide to lower risk for cardiovascular events among adults with overweight or obesity and preexisting CVD, according to new guidance from the Centers of Medicare & Medicaid Services.
Q&A: People with diabetes can benefit from whole foods, plant-based eating plan
Susan Weiner, MS, RDN, CDCES, FADCES, talks with Lauren Plunkett, RDN, LD, CDCES, about benefits of plant-based nutrition for people with diabetes and strategies for incorporating whole foods and plants into eating plans.
Cardiovascular disease risk in gout highest for women, young people
Excess risk for cardiovascular disease in patients with gout — including heart failure and arrhythmias — is highest among women and those aged younger than 45 years, according to data published in The Lancet Rheumatology.
Clinical decision support system may improve hypertension management in adults with CKD
A computerized clinical decision support system could improve the management of uncontrolled hypertension in adults with chronic kidney disease, according to published data.
Bariatric surgery tied to improved cardiometabolic health, lower CVD risk
Adults with obesity who underwent bariatric surgery had improvements in multiple cardiometabolic measures after surgery, according to findings published in the Journal of the Endocrine Society.
FLOW: Semaglutide slows CKD progression, cuts risks for kidney, CV death in diabetes
Adults with type 2 diabetes and chronic kidney disease have a 24% lower risk for kidney disease progression and cardiovascular and kidney mortality with once-weekly semaglutide 1 mg, according to topline results from the FLOW trial.
Study: More stringent algorithms may better define CKD stage G4
Chronic kidney disease stage G3 may be linked with considerable morbidity in a community-based setting, which shows a need for optimized early interventions, according to published data.
Top in women's health: At-home menopause test; migraine, vasomotor symptoms linked to CVD
A new at-home test promises the ability to indicate women’s stage in menopause, but some experts are skeptical about how useful the product actually is.
HHS panel recommends statins for more people with HIV
An HHS panel recommended this week that people with HIV begin taking a statin as young as age 40 years to lower their risk for a serious cardiac event, even if their risk for heart disease is in the low-to-moderate range.
Higher dietary niacin intake linked to lower risk for all-cause mortality in MASLD
Increased intake of dietary niacin may reduce the risk for all-cause mortality but not cardiovascular disease-related mortality among patients with metabolic dysfunction-associated steatotic liver disease, data showed.